What makes a drug quintuple in cost? How do you follow inventing a Covid-19 vaccine? And what did we learn from biotech’s unicorn era?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT’s Ed Silverman joins us to explain how an escalating fight between Vertex Pharmaceuticals and insurance companies has left patients and families caught in the middle. We also discuss the latest news in the life sciences, including the demise of a one-time unicorn, Moderna’s difficult second act, and an official biotech presidential run.